Distinct subtypes of Alzheimer’s disease based on patterns of brain atrophy: longitudinal trajectories and clinical applications

Atrophy patterns on MRI can reliably predict three neuropathological subtypes of Alzheimer’s disease (AD): typical, limbic-predominant, or hippocampal-sparing. A method to enable their investigation in the clinical routine is still lacking. We aimed to (1) validate the combined use of visual rating scales for identification of AD subtypes; (2) characterise these subtypes at baseline and over two years; and (3) investigate how atrophy patterns and non-memory cognitive domains contribute to memory impairment. AD patients were classified as either typical AD (n = 100), limbic-predominant (n = 33), or hippocampal-sparing (n = 35) by using the Scheltens’ scale for medial temporal lobe atrophy (MTA), the Koedam’s scale for posterior atrophy (PA), and the Pasquier’s global cortical atrophy scale for frontal atrophy (GCA-F). A fourth group with no atrophy was also identified (n = 30). 230 healthy controls were also included. There was great overlap among subtypes in demographic, clinical, and cognitive variables. Memory performance was more dependent on non-memory cognitive functions in hippocampal-sparing and the no atrophy group. Hippocampal-sparing and the no atrophy group showed less aggressive disease progression. Visual rating scales can be used to identify distinct AD subtypes. Recognizing AD heterogeneity is important and visual rating scales may facilitate investigation of AD heterogeneity in clinical routine.

• Publication year

  2017

• Venue

  Scientific Reports

• Publication date

  2017-04-18

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/srep46263PMID 28417965PMCID 5394684
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Recommendations

  2020cited by this paper
• Heart rate variability in normal tension glaucoma

  2018cited by this paper
• HYDRA: Revealing heterogeneity of imaging and genetic patterns through a multiple max‐margin discriminative analysis framework

  2017cited by this paper
• Different reserve proxies confer overlapping and unique endurance to cortical thinning in healthy middle-aged adults.

  2016cited by this paper
• Quantitative validation of a visual rating scale for frontal atrophy: associations with clinical status, APOE e4, CSF biomarkers and cognition

  2016cited by this paper
• Cerebrospinal Fluid Biomarkers for the Differential Diagnosis between Alzheimer’s Disease and Frontotemporal Lobar Degeneration: Systematic Review, HSROC Analysis, and Confounding Factors

  2016cited by this paper
• Electroencephalography Is a Good Complement to Currently Established Dementia Biomarkers

  2016cited by this paper
• MRI visual rating scales in the diagnosis of dementia: evaluation in 184 post-mortem confirmed cases

  2016cited by this paper
• Retrospective study

  2016cited by this paper
• White matter hyperintensity burden in elderly cohort studies: The Sunnybrook Dementia Study, Alzheimer's Disease Neuroimaging Initiative, and Three‐City Study

  2016cited by this paper
• Heterogeneity of Regional Brain Atrophy Patterns Associated with Distinct Progression Rates in Alzheimer’s Disease

  2015cited by this paper
• Prediction of Alzheimer's disease pathophysiology based on cortical thickness patterns

  2015cited by this paper
• Practical cut‐offs for visual rating scales of medial temporal, frontal and posterior atrophy in Alzheimer's disease and mild cognitive impairment

  2015cited by this paper
• Measuring Global Brain Atrophy with the Brain Volume/Cerebrospinal Fluid Index: Normative Values, Cut-Offs and Clinical Associations

  2015cited by this paper
• The identification of cognitive subtypes in Alzheimer's disease dementia using latent class analysis

  2015influential reference
• Harmonized diagnostic criteria for Alzheimer's disease: recommendations

  2014cited by this paper
• Subgroups of Alzheimer's Disease: Stability of Empirical Clusters Over Time

  2014cited by this paper
• TheHiveDB image data management and analysis framework

  2014cited by this paper
• Optimizing Patient Care and Research: The Amsterdam Dementia Cohort

  2014cited by this paper
• Cognitive decline is mediated by gray matter changes during middle age.

  2014cited by this paper
• Anatomical heterogeneity of Alzheimer disease

  2014cited by this paper
• Medial temporal lobe atrophy scores translated to clinical practice: Editorial comment on ‘Influence of age, disease onset and ApoE4 on visual medial temporal lobe atrophy cut‐offs'

  2014cited by this paper
• Atrophy of medial temporal lobes on MRI in “probable” Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates

  2012cited by this paper
• Clinical stratification of subtypes of Alzheimer's disease.

  2012cited by this paper
• Neuroimaging correlates of pathologically defined subtypes of Alzheimer's disease: a case-control study.

  2012cited by this paper
• Visual assessment of posterior atrophy development of a MRI rating scale

  2011cited by this paper
• Temporoparietal atrophy: a marker of AD pathology independent of clinical diagnosis.

  2011cited by this paper
• The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

  2011cited by this paper
• Early-onset versus late-onset Alzheimer's disease: the case of the missing APOE ɛ4 allele.

  2011cited by this paper
• Neuropathologically defined subtypes of Alzheimer's disease with distinct clinical characteristics: a retrospective study.

  2011cited by this paper
• Lou Ruvo Center for Brain Health

  2010cited by this paper
• A robust method to estimate the intracranial volume across MRI field strengths (1.5T and 3T)

  2010cited by this paper
• Revising the definition of Alzheimer's disease: a new lexicon.

  2010cited by this paper
• # The Author(s) 2011. This article is published with open access at Springerlink.com

  2010cited by this paper
• An exploration of cognitive subgroups in Alzheimer’s disease

  2009cited by this paper
• The Alzheimer's disease neuroimaging initiative (ADNI): MRI methods

  2008cited by this paper
• Wechsler Memory Scale–Third Edition

  2008cited by this paper
• Variability in cognitive presentation of Alzheimer's disease.

  2008cited by this paper
• Four subgroups of Alzheimer's disease based on patterns of atrophy using VBM and a unique pattern for early onset disease

  2006cited by this paper
• The Alzheimer's disease neuroimaging initiative.

  2005cited by this paper
• Education-stratified base-rate information on discrepancy scores within and between the Wechsler Adult Intelligence Scale--Third Edition and the Wechsler Memory Scale--Third Edition.

  2004cited by this paper
• Qualitative Assessment of Cerebral Atrophy on MRI: Inter- and Intra-Observer Reproducibility in Dementia and Normal Aging

  1997cited by this paper
• The Clinical Dementia Rating (CDR)

  1993cited by this paper
• Atrophy of medial temporal lobes on MRI in "probable" Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates.

  1992cited by this paper
• More powerful procedures for multiple significance testing.

  1990cited by this paper
• Cerebral blood flow in dementia

  1986cited by this paper
• Geriatric Depression Scale (GDS): Recent evidence and development of a shorter version.

  1986cited by this paper
• Measurement of functional activities in older adults in the community.

  1982cited by this paper
• The measurement of observer agreement for categorical data.

  1977cited by this paper
• Cerebral blood flow in dementia.

  1975cited by this paper
• “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician

  1975cited by this paper
• THE ASSESSMENT OF APHASIA AND RELATED DISORDERS

  1973cited by this paper
• Validity of the Trail Making Test as an Indicator of Organic Brain Damage

  1958cited by this paper

• Changes in regional cerebral blood flow associated with psychosis in patients with Alzheimer's disease.

  2026cites this paper
• Subtyping Alzheimer's disease and Parkinson's disease using longitudinal electronic health records.

  2026cites this paper
• Dynamical Aβ-Tau-Neurodegeneration Model Predicts Alzheimer’s Disease Mechanisms and Biomarker Progression

  2026cites this paper
• AI System Using Unsupervised Learning to Discover Novel Subtypes in Alzheimer’s Disease

  2026cites this paper
• Ramp sequence may explain synonymous variant association with Alzheimer’s disease in the Paired Immunoglobulin-like Type 2 Receptor Alpha (PILRA)

  2025cites this paper
• Alzheimer's disease knowledge graph enhances knowledge discovery and disease prediction

  2025cites this paper
• Biological age acceleration in Alzheimer's disease modulates relative cortical to medial temporal lobe neurodegeneration.

  2025cites this paper
• Spectral normative modeling of brain structure

  2025cites this paper
• The association between plasma and MRI biomarkers in dementia with lewy bodies

  2025influential citation
• The Relationship of Prior Concussion and Contact Sport Exposure With Cortical Macro and Microstructure

  2025cites this paper
• Unified Metaheuristic Channel Selection Framework for Medical Image Segmentation

  2025cites this paper
• Unlocking Alzheimer's Disease Heterogeneity: The Role of Normative Modeling, Dynamic Connectivity, and Beyond.

  2025cites this paper
• Reliability assessment of accelerated MR sequences for the estimation of structural and vascular markers in dementia

  2025cites this paper
• The Association between the rs6656401 Locus of the CR1 Gene and Structural Alterations of Brain Effects in Han Chinese Patients with Alzheimer's Disease.

  2025cites this paper
• Ramp Sequence May Explain Synonymous Variant Association with Alzheimer’s Disease in the Paired Immunoglobulin-like Type 2 Receptor Alpha (PILRA)

  2025cites this paper
• Cortical thickness subtypes in cognitively unimpaired individuals: Differential network and transcriptomic vulnerability to cortical thinning

  2025cites this paper
• Validation of dementia-free status in the iranian brain imaging database using ADNI data: a transition point from middle age to older adulthood

  2025cites this paper
• Magnetic Resonance Imaging and Cerebrospinal Fluid Biomarker Clustering Defines Biological Subtypes of Alzheimer’s Disease

  2025cites this paper
• Multimodal and longitudinal characterization of distinct tau and atrophy clusters in Alzheimer’s disease spectrum

  2025cites this paper
• Quantifying Brain Atrophy Using a CSF-Focused Segmentation Approach

  2025cites this paper
• Regional CSF volume quantification using deep learning for comparative analysis of brain atrophy in frontotemporal dementia subtypes

  2025cites this paper
• Modernizing diagnosis of Alzheimer's disease: A review of global trends and Asia‐specific perspectives

  2025cites this paper
• Dissecting real-world memory clinical cohort heterogeneity: analysis of neuroanatomical subtypes using HYDRA

  2025cites this paper
• Longitudinal biomarker studies in human neuroimaging: capturing biological change of Alzheimer’s pathology

  2025cites this paper
• Integrative analysis of proteomic and MRI data reveals protein associations with brain imaging features in Alzheimer’s disease

  2025cites this paper
• Human brain organoids containing microglia that have arisen innately adapt to a β-amyloid challenge better than those in which microglia are integrated by co-culture

  2024cites this paper
• Automated brain segmentation and volumetry in dementia diagnostics: a narrative review with emphasis on FreeSurfer

  2024cites this paper
• Texture‐based morphometry in relation to apolipoprotein ε4 genotype, ageing and sex in a midlife population

  2024cites this paper
• Machine learning on longitudinal multi-modal data enables the understanding and prognosis of Alzheimer’s disease progression

  2024cites this paper
• A large-scale multi-centre study characterising atrophy heterogeneity in Alzheimer's disease

  2024influential citation
• Alzheimer’s Disease Knowledge Graph Enhances Knowledge Discovery and Disease Prediction

  2024cites this paper
• Delineating the Heterogeneity of Alzheimer's Disease and Mild Cognitive Impairment Using Normative Models of the Dynamic Brain Functional Networks.

  2024cites this paper
• Disentangling brain atrophy heterogeneity in Alzheimer's disease: A deep self-supervised approach with interpretable latent space

  2024cites this paper
• Clinical predictors of Alzheimer's disease‐like brain atrophy in individuals with memory complaints

  2024cites this paper
• Predicting progression from subjective cognitive decline to mild cognitive impairment or dementia based on brain atrophy patterns

  2024cites this paper
• Automated Scoring of Alzheimer’s Disease Atrophy Scale with Subtype Classification Using Deep Learning-Based T1-Weighted Magnetic Resonance Image Segmentation

  2024influential citation
• MRI Diffusion Connectomics-Based Characterization of Progression in Alzheimer’s Disease

  2024cites this paper
• Multimodal subtypes identified in Alzheimer’s Disease Neuroimaging Initiative participants by missing-data-enabled subtype and stage inference

  2024cites this paper
• Exploring the Remediation of Behavioral Disturbances of Spatial Cognition in Community-Dwelling Senior Citizens with Mild Cognitive Impairment via Innovative Technological Apparatus (BDSC-MCI Project): Protocol for a Prospective, Multi-Center Observational Study

  2024cites this paper
• Cortical thickness and grey-matter volume anomaly detection in individual MRI scans: Comparison of two methods

  2024cites this paper
• Longitudinal Relationship Between Brain Atrophy Patterns, Cognitive Decline, and Cerebrospinal Fluid Biomarkers in Alzheimer’s Disease Explored by Orthonormal Projective Non-Negative Matrix Factorization

  2024cites this paper
• Microglia measured by TSPO PET are associated with Alzheimer's disease pathology and mediate key steps in a disease progression model

  2024cites this paper
• Mechanistic Approach to Immunity and Immunotherapy of Alzheimer's Disease: A Review.

  2024cites this paper
• Clinical and biological underpinnings of longitudinal atrophy pattern progression in Alzheimer's disease

  2024cites this paper
• Multi-pathological contributions toward atrophy patterns in the Alzheimer’s disease continuum

  2024cites this paper
• Clinical outcome-guided deep temporal clustering for disease progression subtyping

  2024cites this paper
• Increased expression of the proapoptotic presenilin associated protein is involved in neuronal tangle formation in human brain

  2024cites this paper
• The phospho-tau cascade, basal forebrain neurodegeneration, and dementia in Alzheimer's disease: Anti-neurodegenerative benefits of acetylcholinesterase inhibitors

  2024cites this paper
• Personalizing progressive changes to brain structure in Alzheimer's disease using normative modeling

  2024cites this paper
• A generalizable data-driven model of atrophy heterogeneity and progression in memory clinic settings

  2024cites this paper
• Amplifying Efficiency and Accuracy in Dementia Drug Development

  2024cites this paper
• Retrospective Evaluation of Neuropathologic Proxies of the Minimal Atrophy Subtype Compared With Corticolimbic Alzheimer Disease Subtypes

  2023cites this paper
• Structural and functional differences in the brains of patients with MCI with and without depressive symptoms and their relations with Alzheimer's disease: an MRI study

  2023cites this paper
• Pathway-Specific Polygenic Risk Scores Correlate with Clinical Status and Alzheimer’s Disease-Related Biomarkers

  2023cites this paper
• Differential response to donepezil in MRI subtypes of mild cognitive impairment

  2023influential citation
• Development and validation of an automatic classification algorithm for the diagnosis of Alzheimer’s disease using a high-performance interpretable deep learning network

  2023cites this paper
• Alzheimer’s Disease and Its Possible Evolutionary Origin: Hypothesis

  2023cites this paper
• Analyse patient-level heterogeneity in Alzheimer’s Disease using multimodal normative modelling

  2023cites this paper
• A review of neuroimaging-based data-driven approach for Alzheimer’s disease heterogeneity analysis

  2023influential citation
• Distinct subtypes of spatial brain metabolism patterns in Alzheimer’s disease identified by deep learning-based FDG PET clusters

  2023cites this paper
• A global view of the genetic basis of Alzheimer disease

  2023cites this paper
• Should artificial intelligence be used in conjunction with Neuroimaging in the diagnosis of Alzheimer’s disease?

  2023cites this paper
• Associations between different tau-PET patterns and longitudinal atrophy in the Alzheimer’s disease continuum: biological and methodological perspectives from disease heterogeneity

  2023cites this paper
• Redefinition of dementia care in Italy in the era of amyloid-lowering agents for the treatment of Alzheimer’s disease: an expert opinion and practical guideline

  2023cites this paper
• Pathway-specific polygenic risk scores correlate with clinical status and Alzheimer’s-related biomarkers

  2023cites this paper
• Revealing Individual Neuroanatomical Heterogeneity in Alzheimer Disease Using Neuroanatomical Normative Modeling

  2023cites this paper
• MRI data-driven clustering reveals different subtypes of Dementia with Lewy bodies

  2023cites this paper
• Cognitively defined Alzheimer's dementia subgroups have distinct atrophy patterns

  2023cites this paper
• Identification of Genetic Risk Factors Based on Disease Progression Derived From Longitudinal Brain Imaging Phenotypes

  2023cites this paper
• Sex differences in brain atrophy in dementia with Lewy bodies

  2023cites this paper
• Exploring the genetic heterogeneity of Alzheimer’s disease: Evidence for genetic subtypes

  2023cites this paper
• Normative Modeling Using Multimodal Variational Autoencoders to Identify Individual Heterogeneity in Alzheimer’s Disease

  2023cites this paper
• Sex differences in brain atrophy in dementia with Lewy bodies

  2023cites this paper
• The Memory Alteration Test Is Correlated with Clinical, Cerebrospinal Fluid, and Brain Imaging Markers of Alzheimer Disease in Lima, Peru

  2023influential citation
• Alzheimer's Disease Classification Using Cluster-based Labelling for Graph Neural Network on Tau PET Imaging and Heterogeneous Data

  2022cites this paper
• Combining visual rating scales to identify prodromal Alzheimer's disease and Alzheimer's disease dementia in a population from a low and middle-income country

  2022cites this paper
• Assessment of Alzheimer's Disease Imaging Biomarkers in World Trade Center Responders with Cognitive Impairment at Midlife

  2022cites this paper
• Revealing Individual Neuroanatomical Heterogeneity in Alzheimer's Disease

  2022cites this paper
• Disentangling tau and brain atrophy cluster heterogeneity across the Alzheimer's disease continuum

  2022cites this paper
• Neuropathologic Features of Antemortem Atrophy-Based Subtypes of Alzheimer Disease

  2022cites this paper
• The Immune System as a Therapeutic Target for Alzheimer’s Disease

  2022influential citation
• Emotion Processing Dysfunction in Alzheimer’s Disease: An Overview of Behavioral Findings, Systems Neural Correlates, and Underlying Neural Biology

  2022cites this paper
• Characterization of Alzheimer’s Disease Subtypes Based on Magnetic Resonance Imaging and Perfusion Single-Photon Emission Computed Tomography

  2022cites this paper
• Alzheimer’s Disease: Key Insights from Two Decades of Clinical Trial Failures

  2022cites this paper
• Hippocampal Atrophy Subtypes of Alzheimer’s Disease Using Automatic MRI in a Memory Clinic Cohort: Clinical Implications

  2022cites this paper
• Familial factors, depression and cognitive decline: A longitudinal mediation analysis based on latent growth modeling (LGM)

  2022cites this paper
• Macrostructural brain alterations at midlife are connected to cardiovascular and not inherited risk of future dementia: the PREVENT-Dementia study

  2022cites this paper
• Association of Brain Volume and Retinal Thickness in the Early Stages of Alzheimer’s Disease

  2022cites this paper
• Synaptic loss and gliosis in the nucleus tractus solitarii with streptozotocin-induced Alzheimer's disease.

  2022cites this paper
• Alzheimer's disease classification using cluster‐based labelling for graph neural network on heterogeneous data

  2022cites this paper
• Parsing heterogeneity within dementia with Lewy bodies using clustering of biological, clinical, and demographic data

  2022influential citation
• Neuropathologic Features of Antemortem Atrophy-Based Subtypes of Alzheimer Disease

  2022cites this paper
• Memory Binding Test and Its Associations With Hippocampal Volume Across the Cognitive Continuum Preceding Dementia

  2022cites this paper
• Data-Driven Analyses of Longitudinal Hippocampal Imaging Trajectories: Discrimination and Biomarker Prediction of Change Classes

  2022cites this paper
• Potential Mechanisms Underlying Resistance to Dementia in Non-Demented Individuals with Alzheimer’s Disease Neuropathology

  2022cites this paper
• Imaging markers of cerebral amyloid angiopathy and hypertensive arteriopathy differentiate Alzheimer disease subtypes synergistically

  2022influential citation
• The role of trimethylamine‐N‐Oxide in the development of Alzheimer's disease

  2021cites this paper
• Comparison and aggregation of event sequences across ten cohorts to describe the consensus biomarker evolution in Alzheimer’s disease

  2021cites this paper
• Pursuit of precision medicine: Systems biology approaches in Alzheimer’s disease mouse models

  2021cites this paper
• An Interactive Hippocampus-Parahippocampus Functional 3D Connectivity Modeling with Quadratic Detrending

  2021cites this paper